GLP-1 medicines for weight and binge eating in teens and young adults
Part of Mental health clinical trials.
This study looks at how GLP-1 weight-loss medicines affect weight and eating habits in young people. If you struggle with binge eating and are starting such a medication, this could help guide your treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 12 to 21 years old.
- You have binge eating symptoms (eating quickly a lot of food and feeling you can't stop).
- You are about to start or have recently started your first weight-loss injection or pill from the GLP-1 group (like Ozempic, Rybelsus, Wegovy).
- Your weight meets the standard for these medicines (BMI in the high range, often over 30 for adults, or lower if you have a weight-related condition).
- You can get the medicine through insurance, pay yourself, or use a discount plan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how starting a GLP-1 medication (like Wegovy or Ozempic) changes your food choices and eating habits. It may help you understand if these medicines work for weight loss.
This trial tests whether a medication (liraglutide) plus behavioral counseling helps people with severe obesity and binge-eating disorder reduce binge episodes, lose weight, and improve coping. Participants will receive either liraglutide or placebo, along with group therapy sessions.
This study tests whether a newer class of weight-loss medicines (GLP-1 and GIP/GLP-1 analogues) can help people with excess body weight eat healthier and improve their metabolism and behavior. It may be a good option if you are an adult with overweight or obesity and haven't used these medicines recently.
This trial looks at how GLP-1 receptor agonist medications (like liraglutide or semaglutide) affect bone health in adolescents and young adults with obesity. It aims to understand if these weight loss drugs have any impact on bone density and metabolism.
This study tests an investigational medication called ecnoglutide to help teenagers lose weight. It is for teens who still have excess weight after trying diet and exercise for at least three months.
This trial tests a medication for children and teens with obesity or overweight who have not been able to lose enough weight with diet and exercise alone. It aims to see if a new treatment can help them safely lose weight and improve related health problems.
Hear when a new Weight Management trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.